You can always do more with more.

368

FDA believes meetings like this are essential to foster and cultivate the necessary cooperation to continue to keep our drugs safe.

265

It expresses our concern that, over time, the labels became cluttered with a lot of information that wasn't necessarily directly pertinent to the patient and the physician. These labels need to be reclaimed for patients and physicians.

164

There is a disconnect between the investment we're making in discovering treatments and the result in practical treatments that are reaching patients. We think that there are scientific approaches we could be taking that would help us learn more about drugs in a shorter time and for less cost.

159

We are going to initiate a public process for trying to gather information for what additional guidelines we could issue to make sure that these ads are providing truthful and non-misleading information.

147

This approval is another example of our agency's endeavor to counter rising health care costs by approving safe and effective generic alternatives as soon as the law permits.

146

But as generic drugs continue to play an increasingly prominent role in the health of Americans, we need to also continue to make sure that the generic drug program remains on stable financial footing.

145

One of the most important decisions people can make about their health is the choice of foods they eat. A top priority at FDA is finding additional ways to clearly communicate the health benefits found in food.

144

We must do more than ever to monitor the performance of (device) products after they are approved, and make sure that we are quickly discovering and sharing information about problems that do arise.

144

You are unlikely to see our science-based approach change just because of shifts in the public discourse.

140

Our new drugs program has benefited from funding tools that are not available to us when it comes to generic drugs.

121

When you are speaking to consumers, [15-second spots] don't provide any opportunity to give information on disease awareness.

114